Prosecution Insights
Last updated: October 25, 2026

Apollon Inc.

Technology area: Medical Devices & Mechanical Engineering

4 pending office actions • 1 art units • 1 examiners • 0 of 4 (0%) have an AI response strategy ready • 6 patents granted in the last 365 days

Analysis

Apollon Inc. currently manages 4 pending office actions within the Medical Devices & Mechanical Engineering technology area. These filings are all assigned to 1 distinct examiner, creating a centralized prosecution environment for the company. Such a structure allows for a unified response strategy across all pending matters, ensuring that arguments made in one case do not contradict those in another. This level of concentration can be advantageous for building a cohesive patent family where each individual application supports the broader technical disclosures of the company.

The portfolio is active in 1 distinct art unit, suggesting that the pending matters are closely related in their technical scope. LIU, CHU CHUAN, is the busiest examiner, currently handling 4 pending office actions. The outcome of these cases will likely be heavily influenced by this examiner's specific interpretation of the prior art and their understanding of the company's innovations. Practitioners should carefully monitor the progress of each application to identify any emerging patterns in the examiner's feedback that could impact the entire portfolio.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

4
Total Pending OAs
1
Non-Final OAs
3
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

3
Overdue
0
Due this week
1
Due this month
0
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (3)Due ≤ 30 days (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (25%)
3
Medium (75%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Double-patenting + other3 (75%)
Multi-statute (no §101)1 (25%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
4
Mechanical / Eng
100% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

40 h
Manual time on pending OAs
8 h
Time saved (low, 20%)
14 h
Time saved (mid, 35%)
0.3 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
LIU, CHU CHUAN 4 71.3% +14.9%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18427912 RAMAN SPECTROSCOPY METHOD FOR BLOOD GLUCOSE MEASUREMENT LIU, CHU CHUAN 9d

Interview Candidates (4)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.

App #TitleExaminerDue in
18427880 APPARATUS FOR BLOOD GLUCOSE MEASUREMENT BASED ON RAMAN SPECTROSCOPY COMPRISING LINEAR VARIABLE FILTER LIU, CHU CHUAN 42d overdue
18427879 APPARATUS FOR BLOOD GLUCOSE MEASUREMENT BASED ON RAMAN SPECTROSCOPY COMPRISING FILTER ARRAY LIU, CHU CHUAN 42d overdue
18427873 APPARATUS FOR BLOOD GLUCOSE MEASUREMENT BASED ON RAMAN SPECTROSCOPY LIU, CHU CHUAN 1d overdue
18427912 RAMAN SPECTROSCOPY METHOD FOR BLOOD GLUCOSE MEASUREMENT LIU, CHU CHUAN 9d

Top Art Units

Art UnitApps
3791 4

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18427912 RAMAN SPECTROSCOPY METHOD FOR BLOOD GLUCOSE MEASUREMENT LIU, CHU CHUAN 3791 §103§112Other Non-Final OA 9d Pending Jan 31, 2024
18427873 APPARATUS FOR BLOOD GLUCOSE MEASUREMENT BASED ON RAMAN SPECTROSCOPY LIU, CHU CHUAN 3791 §103DP Final Rejection 1d overdue Pending Jan 31, 2024
18427880 APPARATUS FOR BLOOD GLUCOSE MEASUREMENT BASED ON RAMAN SPECTROSCOPY COMPRISING LINEAR VARIABLE FILTER LIU, CHU CHUAN 3791 §103DP Final Rejection 42d overdue Pending Jan 31, 2024
18427879 APPARATUS FOR BLOOD GLUCOSE MEASUREMENT BASED ON RAMAN SPECTROSCOPY COMPRISING FILTER ARRAY LIU, CHU CHUAN 3791 §103DP Final Rejection 42d overdue Pending Jan 31, 2024

Managing Apollon Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Apollon Inc. have?

Apollon Inc. has 4 pending office actions as of October 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most Apollon Inc. applications?

Chu Chuan Liu has the most, with 4 of Apollon Inc.'s pending office actions.

What technology area are Apollon Inc.'s patent applications in?

Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month